Factors Related to Anxiety, Depressive Symptoms and Quality of Life in Breast Cancer

Cáceres, Macarena C.; Nadal-Delgado, Marta; López-Jurado, Casimiro Fermín; Pérez-Civantos, Demetrio; Guerrero-Martín, Jorge; Durán-Gómez, Noelia

doi:10.3390/ijerph19063547

Cited by 10 publications

(10 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a Spanish population, women with breast cancer undergoing different types of treatment were found to have higher levels of anxiety among patients at advanced stages compared to other stages (Cáceres et al, 2022 ). Thinh et al ( 2018 ) reported that psychological distress was prevalent in 56.3% of participants in six South East Asian countries (Indonesia, Malaysia, Philippines, Singapore, Thailand, and Vietnam).…”

Section: Discussionmentioning

confidence: 99%

Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review

Ostovar

Chahardehi

Hashim

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

Psychological distress (including depression and anxiety) is common in the first years of cancer diagnosis but can differ by country and region. The aim of the present paper was to review the prevalence of psychological distress among cancer patients in the Southeast Asia (SEA) region. A systematic literature search was carried out using several databases (i.e., PubMed, PsychARTICLES, Embase, CINAHI, Web of Sciences, Plus, Scopus, and AHMED). Papers originally published in English language were taken into consideration if they (i) were published from 2010 to 2021 and (ii) reported the prevalence of psychological distress among patients with different types of cancer. A total of 23 studies met the inclusion criteria. The most frequently employed psychometric instrument for anxiety and depression screening was the Hospital Anxiety and Depression Scale (HADS). The prevalence of anxiety (ranging from 7% to 88%) was wider than that of depression (ranging from 3% to 65.5%) among patients with different types of cancer and living in various countries in the SEA region. The overall prevalence rate of psychological distress among cancer patients from the SEA region was not fundamentally very different from that of general populations. These findings provide useful information for health professionals and cancer patients to understand the negative role of psychological distress in quality of life and health. The research findings demonstrate the importance of counselling for psychological distress among cancer patients as means of effectively resolving their psychological problems and ultimately improving the quality of oncology medical care. Clinical recommendations for cancer management should incorporate the early identification of (and therapy for) psychological distress, as well as their monitoring during treatment.

show abstract

Section: Discussionmentioning

confidence: 99%

Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review

Ostovar

Chahardehi

Hashim

et al. 2022

European J Cancer Care

View full text Add to dashboard Cite

show abstract

“…Goldney et al [ 44 ] demonstrated that the QoL of individuals with depression was lower than in individuals with the same disease but without depressive symptoms. This result was also evidenced in breast cancer patients [ 42 ], mainly in those individuals with several sessions of chemotherapy and more severe disorders [ 42 ]. Thus, due to the possibility of depression symptoms persisting after the cure of the disease, which would directly impact the QoL in this population, depression should be considered an important condition to be prevented and treated, especially in breast cancer survivors.…”

Section: Discussionmentioning

confidence: 74%

“…The age (i.e., younger patients), socioeconomic level (i.e., lower income), and level of disease (i.e., severe disease) increase the depression level in breast cancer patients [ 41 ]. The time of diagnosis, the type of adjuvant treatment (i.e., chemotherapy), and the number of chemotherapies were related to the presence of depressive symptoms in breast cancer patients [ 42 ]. It should be highlighted that depressive symptoms can occur during treatment and also persist after the cure of the disease [ 18 ].…”

Section: Discussionmentioning

confidence: 99%

“…In addition, cancer symptoms associated with depression may be more intense when there is persistent depression, which has a negative impact on physical, emotional, and social health [ 21 ]. Moreover, as mentioned previously, depressive symptoms associated with some characteristics of the disease (e.g., number of chemotherapy sessions and disease severity) exacerbate the impairment in the QoL of this population [ 42 ]. Such a circumstance may justify the results of this study, since breast cancer survivors who remained depressed over the course of a year presented worse QoL when compared to those without depression.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of Quality of Life in Breast Cancer Survivors with and without Persistent Depressive Symptoms: A 12-Month Follow-Up Study

Ribeiro

Tebar

Ferrari

et al. 2023

IJERPH

View full text Add to dashboard Cite

Although breast cancer treatments reduce mortality, their adverse effects can increase depression which impacts one’s quality of life (QoL). Physical activity (PA) seems to improve the QoL of breast cancer survivors (BCS). However, an unanswered question is the influence of PA on the QoL in BCS with depressive symptoms. Thus, we analyzed the influence of PA on the QoL in BCS with persistent depressive symptoms during 12 months of follow-up. The sample included 70 female BCS. Depression and QoL domains (i.e., functional capacity, physical limitations, body pain, general health status, vitality, social and emotional aspects, and mental health) were assessed at baseline and follow-up periods by the Hospital Anxiety and Depression Scale and SF-36, respectively. Habitual PA was assessed by Baecke’s questionnaire. Our results indicate a prevalence of 17.1% of depressive symptoms. Non-depressives BCS improved their physical limitations and general health status domains over time, but there were no observed differences in depressive BCS. BCS with persistent depressive symptoms (baseline and follow-up) showed worse QoL scores than non-depressives in all domains, regardless of confounding factors. When adjusted for PA, the difference between BCS depressives and non-depressives lost its significance in the functional capacity domain. In conclusion, habitual PA practice positively influenced the functional capacity domain of the QoL in BCS.

show abstract

“…1 Although the survival trend of cancer is generally increasing, 2 there is still lack of effective strategies for most types of cancers to provide a complete cure or long-term-effective treatment. 3 Moreover, due to the rapid progress of the cancer, patients with advanced cancer have a higher burden of symptoms, suffering more prevalent and intense physical symptoms and emotional disorders, such as fatigue, nausea, pain, depression, anxiety, etc, 4,5 and are associated with more impaired quality of life, 4,6,7 compared with their counterparts at the early stage. Among this population, there is a subgroup with low socioeconomic status.…”

Section: Introductionmentioning

confidence: 99%

Living experiences of people with advance cancer with low socioeconomic status: A systematic review of qualitative evidence

Meng

et al. 2022

Palliat Med

View full text Add to dashboard Cite

Background: The number of patients with advanced cancer is rapidly increasing, and the subgroup of this population with low socioeconomic status has suffered more disease burden than others. However, there is no recent qualitative synthesis of primary research studies into advanced cancer patients with low socioeconomic status. Objective: To synthesise qualitative research findings into advanced cancer patients’ experiences with low socioeconomic status, and then to help provide targeted and effective strategies to improve their quality of life. Design: A systematic review and meta-synthesis of qualitative evidence (PROSPERO: CRD42021250423). Data sources: PubMed, Web of Science Core Collection (ISI Web of Science), Cochrane Library, Embase, OVID LWW, CINAHL Complete (EBSCO), PsycINFO (EBSCO) and MEDLINE (ISI Web of Science), China National Knowledge Infrastructure (CNKI), WangFang, and Vip databases were systematically searched from their original dates to July 2022. Qualitative data were appraised using the Joanna Briggs Institute (JBI) qualitative assessment. Findings: The findings were synthesised into the following three analytical themes: (1) multi-dimensional disease distresses; (2) barriers in coping with disease distresses; and (3) strategies for dealing with disease distresses. Conclusions: Patients with advanced cancer with low socioeconomic status experienced complicated and interactional distresses, unique life barriers, and a wide range of adaptation strategies. These findings will provide a comprehensive perspective to promote individual-centred health care systems and services to help these vulnerable people deal with the challenges of disease and improve their quality of life.

show abstract

Factors Related to Anxiety, Depressive Symptoms and Quality of Life in Breast Cancer

Cited by 10 publications

References 55 publications

Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review

Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review

Comparison of Quality of Life in Breast Cancer Survivors with and without Persistent Depressive Symptoms: A 12-Month Follow-Up Study

Living experiences of people with advance cancer with low socioeconomic status: A systematic review of qualitative evidence

Contact Info

Product

Resources

About